Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Cheniere Energy: A Bullish Setup for More Gains

LNG producer Cheniere Energy is on track to rise by $75 in 2025 as demand trends support DCF growth, dividends, and share buybacks.

Hedge Funds Loaded Up AI Stocks at the Fastest Pace Since 2021

Hedge Funds Loaded Up AI Stocks at the Fastest Pace Since 2021

Hedge funds are back into AI stocks at the fastest pace since 2021, reiterating the fact that there is much more upside to be had in them.

Robinhood: The Future Still Looks Bright Despite +300% Rise

Robinhood: The Future Still Looks Bright Despite +300% Rise

Robinhood Markets kicked off 2025 with a fantastic earnings report. There is reason to believe this company can continue to grow strongly.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Oversold Stocks Flashing a Key Technical Breakout Signal

These three stocks are trading below their 200-day SMAs; however, each stock has catalysts that may move each stock higher

3 Stocks Offering Strong Value and Stability

These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.

The Uranium Supercycle: Top 3 Plays to Lead the Nuclear Revival

The convergence of booming energy demands with severely constrained supplies positions uranium mining for substantial price increases.

5 S&P 500 Dividend Stocks Set to Reward Investors

This article introduces readers to five stocks included in the S&P 500 index that also offer dividend yields of at least 2.78%.

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Genuine Parts Company Is a Royally Good Buy Right Now

Why Genuine Parts Company Is a Royally Good Buy Right Now

Genuine Parts Company stock is at its bottom and setting up for a rebound in 2025 that could add double digits to its stock price.

Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch

Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch

The industrial sector, represented by the XLI, has outpaced the broader market in 2025, driven by reshoring, infrastructure, and technological advancements.

These 5 Energy Stocks Hedge Inflation With Growth Potential

These 5 Energy Stocks Hedge Inflation With Growth Potential

This article explore five energy stocks with higher anticipated potential upsides, which can provide growth potential in high-inflation environments.

Unity Stock: Is a True Turnaround Finally Taking Shape?

Unity Stock: Is a True Turnaround Finally Taking Shape?

Unity Software's stock surged after a strong earnings beat and positive developments fueled by strategic shifts and a promising new AI advertising platform.

DuPont’s Electronics Spinoff: The Start of Something Big

DuPont’s Electronics Spinoff: The Start of Something Big

DuPont initially sought to split into 3 public companies, but will instead keep the Water division and speed up the spin-off of its Electronic division in Nov

The Trade Desk Crashes on Earnings, But Growth Catalysts Persist

The Trade Desk Crashes on Earnings, But Growth Catalysts Persist

Markets dumped Trade Desk shares after earnings. However, the firm can still benefit from long-term growth drivers like connected TV.

Market Shift: These 3 Stocks Are Winning While Big Tech Lags

Market Shift: These 3 Stocks Are Winning While Big Tech Lags

Mid-to-large-cap stocks like BROS, DOCS, and HOOD have seen substantial gains as the market rewards positive earnings from mid to modest large-cap stocks.

Get all your
news in one place.

100’s of premium titles.
One news app.

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Gilead Pharmaceuticals is back to highs not seen in a decade as its HIV treatment franchise surges and awaits its 100% effective HIV prevention drug in summer

MarketBeat Week in Review – 02/17 - 02/21

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news

SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?

SolarEdge Technologies defied the industry downturn with a revenue beat and positive free cash flow, prompting a rally and turn-around discussion.

3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom

With NVIDIA delivering more growth this year, three stocks could benefit greatly from its success, with more upside of their own.

Get all your
news in one place.

100’s of premium titles.
One news app.

MercadoLibre: High-Growth EM Stock With 100% Upside Potential

MercadoLibre is Latin America's leading eCommerce platform and is on track to see its share price rise by at least 100% within the next two to three years.

As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum

After two years of strong gains from the Magnificent 7, the rotation trade is gaining steam; here are three stocks for growth-oriented investors to consider

Gold's Ascent: Can Miners and ETFs Take Investors to $3,000?

Geopolitical forces, economic shifts, and central bank actions are fueling a gold surge, creating investment options through mining stocks and ETFs.

Medtronic’s Expansion Gains Momentum—Time for a Market Shift?

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains

This article introduces four high-tech stock picks that feature P/E ratios less than 20 and positive analyst estimates for share price.

Palantir Stock Skids—How Much Further Can It Fall?

PLTR stock is down more than 17%; investors wonder if the stock is setting up for a knock-out blow or if it can get up off the map and surge higher

Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?

Recursion Pharmaceuticals' stock has soared due to Nvidia's continued investment, positioning the company as a leader in AI-driven drug discovery.

1 … 35 36 37 38

People

113,098 stories

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

268,528 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play